openPR Logo
Press release

Sequencing Reagents Market to grow at a CAGR of 12.5% to reach US$ 14,195.60 million from 2020 to 2028

12-08-2021 06:54 PM CET | Health & Medicine

Press release from: The Insight Partners

Sequencing Reagents market

Sequencing Reagents market

Sequencing reagents are used during the process of sequencing. The use of these reagents highly depends on the desired result to be obtained. They form an essential part of the sequencing reactions, which can be used across various other applications as well. An increase in R&D activities worldwide is expected to drive the growth of the market during the forecast period.

Genomic sequencing is rapidly transitioning into clinical practice, and implementation into healthcare systems has been supported by substantial government investment, totaling over US$ 4 billion in at least 14 countries. These national genomic-medicine initiatives are driving transformative change under real-life conditions while simultaneously addressing barriers to implementation and gathering evidence for broader adoption, thereby driving the market growth.
The factors such as growing funding for genomics, declining cost of sequencing procedures, and increasing prevalence of chronic diseases drive the growth of the global sequencing reagents market. However, the dearth of skilled professionals hinders the market growth.

To get sample Copy of the report, along with the TOC, Statistics @ https://www.theinsightpartners.com/sample/TIPRE00006817/?utm_source=OpenPR&utm_medium=10389

Here we have listed the top Sequencing Reagents Market companies

BGI Group; F. Hoffmann-La Roche Ltd.; Fluidigm Corporation; Illumina, Inc.; LGC Biosearch Technologies; Pacific Biosciences of California, Inc.; Qiagen; Takara Bio, Inc.; Thermo Fisher Scientific, Inc.; and Trilink Biotechnologies.

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Based on technology, the global sequencing reagents market is segmented into next generation sequencing, Sanger sequencing, and third generation sequencing. In 2020, the next generation sequencing segment held the largest share in the market. Based on reagent type, the global sequencing reagents market is segmented into control kits, library kits, template kits, sequencing kits, and other reagent types. The control kits segment held the largest market share in 2020, and it is further expected to dominate the market by 2028. Based on application, the global sequencing reagents market is segmented into Agrigenomics and forensics, clinical investigation, oncology, reproductive health, and other applications. The oncology segment held the largest market share in 2020

The Covid-19 (coronavirus) pandemic is impacting society and the overall economy across the world. The impact of this pandemic is growing day by day as well as affecting the supply chain. The COVID-19 crisis is creating uncertainty in the stock market, massive slowing of supply chain, falling business confidence, and increasing panic among the customer segments. The overall effect of the pandemic is impacting the production process of several industries including Biotechnology, medical devices, pharma Industry, and many more. Trade barriers are further restraining the demand- supply outlook. As government of different regions have already announced total lockdown and temporarily shutdown of industries, the overall production process being adversely affected; thus, hinder the overall Sequencing Reagents market globally. This report on ‘Sequencing Reagents market’ provides the analysis on impact on Covid-19 on various business segments and country markets. The report also showcases market trends and forecast to 2028, factoring the impact of Covid -19 Situation.

ASSESING THE COVID-19 IMPACT on Sequencing Reagents Market? Visit Here for PDF Copy >>
https://www.theinsightpartners.com/covid-analysis-sample/TIPRE00006817/?utm_source=OpenPR&utm_medium=10389

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Sequencing Reagents Market based on product and application. It also provides market size and forecast till 2028 for overall Sequencing Reagents Market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America (SAM), which is later sub-segmented by respective countries and segments. The report evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend and provides exhaustive PEST analysis for all five regions.

Place a Purchase Order to Buy a Complete Copy of this Report @ https://www.theinsightpartners.com/buy/TIPRE00006817/?utm_source=OpenPR&utm_medium=10389

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense, Food & beverage, Chemical and Materials, Semiconductors etc.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

...

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Sequencing Reagents Market to grow at a CAGR of 12.5% to reach US$ 14,195.60 million from 2020 to 2028 here

News-ID: 2490655 • Views: 133

More Releases from The Insight Partners

RNAi Therapeutics Market Report Analysis 2022, Growth Prospects, Industry Size, …
RNAi refers to the interference RNA which is responsible to control and manipulate protein translation in the cell. These RNAi are used to silence particular genes that are responsible for diseases. At present, the awareness about RNAi is increasing due to its ability to offer target specific mechanism, leading to superior treatment outcomes. The approach is widely utilized for drug development. Get PDF Sample Copy of this Report https://www.theinsightpartners.com/sample/TIPRE00007157/?utm_source=OpenPR&utm_medium=10396 Increasing investments
Drug Discovery Outsourcing Market Size 2022 Global Comprehensive Research Study, …
As the process of new drug discovery is getting more expensive and time consuming most of the pharmaceutical and biotech market players are focusing on outsourcing solutions. Generally, drug discovery outsourcing solution comprised of development and testing of pipeline drug molecules. Pharmaceutical companies are increasingly outsourcing research activities to academic and private contract research organizations (CROs) in order to stay competitive in market. Click to GET PDF at https://www.theinsightpartners.com/sample/TIPRE00016852/?utm_source=OpenPR&utm_medium=10396 Market for drug
Custom Antibody Market Giants Spending is Going to Boom with Size, Share, Demand …
Customized antibodies can be generated in a mouse, rat, or hamster, to meet any host requirements. Companies are providing wide range of antibodies according to the researcher's requirements. There are variety of customized antibodies in the market which includes polyclonal and monoclonal antibody, recombinant monoclonal antibody, hybridoma antibody, polyclonal recombinant antibody, and others. Companies are offering complete support services for all types and steps of antibody production from peptide design,
Parkinsons Disease Treatment Market 2022 Industry Size, Share, Business Strategi …
Parkinson's disease is a degenerative nervous system disorder that affects people's ability to move. Parkinson's disease symptoms begin slowly, with tremors in one hand that are barely noticeable. Stiffness, rigid muscles, impaired posture and balance, loss of automatic movement, and slowness of movement are common symptoms of the disease. The Parkinson's disease cannot be completely cured, drugs can help to relieve its symptoms. Parkinson's disease treatment consist of use of

All 5 Releases


More Releases for Sequencing

Next Generation Sequencing Market Growth of Technological Advancements in Sequen …
Research Report on Next Generation Sequencing Market providing Global Industry Scenario for 5 years (2019 to 2026) is now available under the Life Sciences Section of Search4Research.com Get Research Sample PDF at https://www.search4research.com/request-sample/113582/ Global Next Generation Sequencing Market Trends, Competitive Analysis and Forecast Report 2018-2026 is an exhaustive study on the present market scenario of the global Next Generation Sequencing industry with a special focus on the United States, Europe,
Metagenomic Sequencing Market Technology Outlook 2027 - 16s Rrna Sequencing, Sho …
Worldwide Metagenomic Sequencing Market Analysis to 2027 is a specialized and in-depth study of the Metagenomic Sequencing Industry with a focus on the global market trend. The report aims to provide an overview of global Metagenomic Sequencing Market with detailed market segmentation by product/application and geography. The global Metagenomic Sequencing Market is expected to witness high growth during the forecast period. Metagenomics, is a field where genomic analysis of microbial DNA
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may
Precision Medicine Market Report 2018: Segmentation by Technology (Genomics, Tra …
Global Precision Medicine market research report provides company profile for Abbott Laboratories, Almac Group, Ltd, Asuragen, Inc., Cepheid Inc, Cetics Healthcare Technologies GmbH, Ge Healthcare, Glaxosmithkline Plc, Intomics A/S., Biocrates Life Sciences Ag, Pfizer Inc. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth
Next Generation Sequencing (NGS) Market, By Technology (Whole Exon Sequencing (W …
The next generation sequencing market is estimated to represent a global market of USD 5,618 million by 2017 with growth rate of 9.1%. Next-generation sequencing (NGS) involves an advanced level of genetic sequencing which is a level above the conventional methods such as capillary electrophoresis-based Sanger sequencing. NGS procedure is a multi-step process where a number of smaller laboratory processes combine to form the whole next-generation sequencing process. This includes
Next Generation Sequencing Market Global Analysis and Forecasts by Service (Geno …
ReportsWeb.com has announced the addition of the “Next Generation Sequencing Market to 2025”, the report classifies the global Next Generation Sequencing Market in a precise manner to offer unearth valuable, accurate and reliable data insights that help organizations to meet their business objectives and enable growth. The next generation market is estimated to account for US$ 26,501.2 Mn by the end of 2025, escalating at a CAGR of 21.1% during the